APA (7th ed.) Citation

MP, K., H, L., S, W., F, M., J, K., & W, L. (2023). Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine. Clinical and translational science, 16(4), 593. https://doi.org/10.1111/cts.13471

Chicago Style (17th ed.) Citation

MP, Kosloski, Li H, Wang S, Mensa F, Kort J, and Liu W. "Characterizing Complex and Competing Drug-drug Interactions Between the Antiviral Regimen of Glecaprevir and Pibrentasvir with Rifampin or Carbamazepine." Clinical and Translational Science 16, no. 4 (2023): 593. https://doi.org/10.1111/cts.13471.

MLA (9th ed.) Citation

MP, Kosloski, et al. "Characterizing Complex and Competing Drug-drug Interactions Between the Antiviral Regimen of Glecaprevir and Pibrentasvir with Rifampin or Carbamazepine." Clinical and Translational Science, vol. 16, no. 4, 2023, p. 593, https://doi.org/10.1111/cts.13471.